With newly diagnosed cancer of the oropharynx, oral cavity, colon or liver (at any stage).
For whom first-line treatment has been decided including radiotherapy, chemotherapy, immunotherapy and/or surgery.
Able to follow all study procedures in accordance with the protocol.
Have given their oral, free and informed consent to participate in the study.
You may not be if
Person not affiliated with national health insurance system
Person subject to a legal protection measure (curatorship, guardianship)
Pregnant women, women in labour or breastfeeding mothers
Adults who is unable to give consent
Minors
Person unable to read, speak, write and understand French
Patients with neuro-cognitive disorders (post-stroke, dyslexia, dyspraxia) or neuro-psychiatric disorders (dementia, autism) that make it impossible to assess taste sensoriality.
Patients with olfactory or gustatory disorders documented prior to the disease
Patient with another cancer currently being treated
Patients with a systemic disease or physical trauma affecting taste perception
Patients with kidney failure
Patients with sinonasal polyposis
Patients undergoing immunosuppressive treatment
Patients with an estimated life expectancy of less than 3 months
Clareo Health | Oncology, Undernutrition and Sensoriality: Links, Mechanisms and Levers for Action
